Detalhe da pesquisa
1.
Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy.
PLoS Pathog
; 17(7): e1009278, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34228762
2.
Addendum: Immune clearance of highly pathogenic SIV infection.
Nature
; 547(7661): 123-124, 2017 07 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28636599
3.
Optimization and use of near infrared imaging to guide lymph node collection in rhesus macaques (Macaca mulatta).
J Med Primatol
; 51(5): 270-277, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35841132
4.
MHC-E-Restricted CD8+ T Cells Target Hepatitis B Virus-Infected Human Hepatocytes.
J Immunol
; 204(8): 2169-2176, 2020 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32161099
5.
Immune clearance of highly pathogenic SIV infection.
Nature
; 502(7469): 100-4, 2013 Oct 03.
Artigo
Inglês
| MEDLINE | ID: mdl-24025770
6.
Rhesus Cytomegalovirus-encoded Fcγ-binding glycoproteins facilitate viral evasion from IgG-mediated humoral immunity.
bioRxiv
; 2024 Feb 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38464092
7.
Late gene expression-deficient cytomegalovirus vectors elicit conventional T cells that do not protect against SIV.
JCI Insight
; 8(6)2023 03 22.
Artigo
Inglês
| MEDLINE | ID: mdl-36749635
8.
Cytomegalovirus-vaccine-induced unconventional T cell priming and control of SIV replication is conserved between primate species.
Cell Host Microbe
; 30(9): 1207-1218.e7, 2022 09 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35981532
9.
Myeloid cell tropism enables MHC-E-restricted CD8+ T cell priming and vaccine efficacy by the RhCMV/SIV vaccine.
Sci Immunol
; 7(72): eabn9301, 2022 06 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35714200
10.
Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission.
Nat Commun
; 12(1): 3343, 2021 06 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34099693
11.
Cytomegaloviral determinants of CD8+ T cell programming and RhCMV/SIV vaccine efficacy.
Sci Immunol
; 6(57)2021 03 25.
Artigo
Inglês
| MEDLINE | ID: mdl-33766849
12.
Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy.
Science
; 372(6541)2021 04 30.
Artigo
Inglês
| MEDLINE | ID: mdl-33766941
13.
CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification.
J Clin Invest
; 131(8)2021 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33630764
14.
Non-bronchoscopic Bronchoalveolar Lavage as a Refinement for Safely Obtaining High-quality Samples from Macaques.
Comp Med
; 70(6): 520-525, 2020 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33153516
15.
Enhancing safety of cytomegalovirus-based vaccine vectors by engaging host intrinsic immunity.
Sci Transl Med
; 11(501)2019 07 17.
Artigo
Inglês
| MEDLINE | ID: mdl-31316006
16.
Characterization of a live-attenuated HCMV-based vaccine platform.
Sci Rep
; 9(1): 19236, 2019 12 17.
Artigo
Inglês
| MEDLINE | ID: mdl-31848362
17.
A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge.
Sci Transl Med
; 11(501)2019 07 17.
Artigo
Inglês
| MEDLINE | ID: mdl-31316007
18.
Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound.
Nat Med
; 24(9): 1430-1440, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30082858
19.
Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine.
Nat Med
; 24(2): 130-143, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29334373
20.
Broadly targeted CD8⺠T cell responses restricted by major histocompatibility complex E.
Science
; 351(6274): 714-20, 2016 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-26797147